A few words of caution on blood purification in sepsis.
作者信息
Stahl Klaus, Wendel-Garcia Pedro David, Bode Christian, David Sascha
机构信息
Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Carl-Neuberg Strasse 1, 30625, Hannover, Germany.
Division of Cardiothoracic and Vascular Anaesthesia and Intensive Care Medicine, Department of Anaesthesia, General Intensive Care and Pain Management, Medical University of Vienna, Vienna, Austria.
出版信息
Crit Care. 2025 Jan 25;29(1):45. doi: 10.1186/s13054-025-05268-z.
Abstract
摘要
相似文献
1
A few words of caution on blood purification in sepsis.关于脓毒症血液净化的几点注意事项。
Crit Care. 2025 Jan 25;29(1):45. doi: 10.1186/s13054-025-05268-z.
2
Predicting the Requirement of Blood Purification in Sepsis Disease Population: Development and Assessment of a New Nomogram.预测脓毒症患者群体的血液净化需求：一种新列线图的开发与评估
Clin Lab. 2025 Jul 1;71(7). doi: 10.7754/Clin.Lab.2025.240936.
3
Efficacy of hybrid blood purification for SA-AKI subtypes identified by CCL14: study protocol for a single-centre randomized controlled clinical trial.基于CCL14鉴定的SA-AKI亚型的混合血液净化疗效：一项单中心随机对照临床试验的研究方案
Trials. 2025 Aug 26;26(1):312. doi: 10.1186/s13063-025-09058-4.
4
PROGNOSTIC IMPLICATIONS OF CHANGES IN PLATELET TRAJECTORIES IN PATIENTS WITH SEPSIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL INFORMATION MART FOR INTENSIVE CARE IV DATABASE.脓毒症患者血小板轨迹变化的预后意义：一项使用重症监护医学信息数据库IV的回顾性分析
Shock. 2025 Mar 1;63(3):371-378. doi: 10.1097/SHK.0000000000002493. Epub 2024 Oct 10.
5
Blood purification and mortality in sepsis: a meta-analysis of randomized trials.血液净化与脓毒症患者的死亡率：一项随机试验的荟萃分析。
Crit Care Med. 2013 Sep;41(9):2209-20. doi: 10.1097/CCM.0b013e31828cf412.
6
Sealing procedures for preterm prelabour rupture of membranes.早产胎膜早破的封闭治疗程序
Cochrane Database Syst Rev. 2016 Jul 7;7(7):CD010218. doi: 10.1002/14651858.CD010218.pub2.
7
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.与每日多次剂量的庆大霉素相比，每日一剂治疗新生儿疑似或确诊败血症。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD005091. doi: 10.1002/14651858.CD005091.pub2.
8
[Clinical study on the effect of glycosaminoglycans on vascular endothelial glycocalyx in sepsis].[糖胺聚糖对脓毒症血管内皮糖萼影响的临床研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):527-534. doi: 10.3760/cma.j.cn121430-20240725-00634.
9
Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives.体外血液净化疗法在脓毒症中的应用：当前模式、现有证据及未来展望
Crit Care. 2024 Dec 25;28(1):432. doi: 10.1186/s13054-024-05220-7.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
引用本文的文献
1
Setting the record straight: revisiting the debate on extracorporeal therapies in sepsis.澄清事实：重温脓毒症体外治疗的争论
Crit Care. 2025 Jun 16;29(1):243. doi: 10.1186/s13054-025-05426-3.
2
Rethinking caution: a critical appraisal of extracorporeal blood purification in sepsis.重新审视谨慎：对脓毒症中体外血液净化的批判性评估
Crit Care. 2025 Mar 19;29(1):123. doi: 10.1186/s13054-025-05353-3.
本文引用的文献
1
Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives.体外血液净化疗法在脓毒症中的应用：当前模式、现有证据及未来展望
Crit Care. 2024 Dec 25;28(1):432. doi: 10.1186/s13054-024-05220-7.
2
Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock.治疗性血浆置换对感染性休克组织因子和组织因子途径抑制剂的影响。
Crit Care. 2024 Oct 30;28(1):351. doi: 10.1186/s13054-024-05142-4.
3
Circulating soluble urokinase plasminogen receptor is reduced by - and predicts early treatment response to therapeutic plasma exchange in septic shock.循环可溶性尿激酶型纤溶酶原受体水平降低，且可预测脓毒性休克患者对治疗性血浆置换的早期治疗反应。
J Crit Care. 2025 Feb;85:154927. doi: 10.1016/j.jcrc.2024.154927. Epub 2024 Oct 9.
4
The phenomenon of desorption: What are the best adsorber exchange intervals?解吸现象：最佳吸附剂更换间隔是多久？
Crit Care. 2024 May 27;28(1):178. doi: 10.1186/s13054-024-04968-2.
5
EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.EXCHANGE-2 研究：评估附加血浆置换作为脓毒性休克辅助治疗策略的疗效—一项针对随机、前瞻性、多中心、开放标签、对照、平行分组试验的研究方案。
Trials. 2023 Apr 15;24(1):277. doi: 10.1186/s13063-023-07300-5.
6
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.在感染性休克中，血浆置换治疗反应的临床和生化终点及预测因素：一项随机对照试验的结果。
Crit Care. 2022 May 12;26(1):134. doi: 10.1186/s13054-022-04003-2.
7
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock.治疗性血浆置换对脓毒性休克患者血管内皮糖萼的影响
Intensive Care Med Exp. 2021 Nov 24;9(1):57. doi: 10.1186/s40635-021-00417-4.
8
High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.高剂量联合血浆滤过吸附治疗感染性休克患者：COMPACT-2 多中心、适应性、随机临床试验结果。
Intensive Care Med. 2021 Nov;47(11):1303-1311. doi: 10.1007/s00134-021-06501-3. Epub 2021 Oct 3.
9
Cytokine adsorption in severe, refractory septic shock.严重难治性脓毒症休克中的细胞因子吸附
Intensive Care Med. 2021 Nov;47(11):1334-1336. doi: 10.1007/s00134-021-06512-0. Epub 2021 Sep 1.
10
Adjuvant therapeutic plasma exchange in septic shock.脓毒性休克的辅助性治疗性血浆置换
Intensive Care Med. 2021 Mar;47(3):352-354. doi: 10.1007/s00134-020-06339-1. Epub 2021 Jan 20.
Zotero 插件